Gator Capital Management LLC Takes Position in Globe Life Inc. $GL

Gator Capital Management LLC acquired a new stake in Globe Life Inc. (NYSE:GL) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 34,395 shares of the company’s stock, valued at approximately $4,810,000. Globe Life comprises approximately 1.0% of Gator Capital Management LLC’s investment portfolio, making the stock its 29th biggest holding.

Several other hedge funds have also modified their holdings of the stock. Macquarie Group Ltd. raised its stake in shares of Globe Life by 88.1% in the fourth quarter. Macquarie Group Ltd. now owns 3,429 shares of the company’s stock valued at $479,000 after acquiring an additional 1,606 shares in the last quarter. Northwest & Ethical Investments L.P. raised its stake in shares of Globe Life by 41.5% in the fourth quarter. Northwest & Ethical Investments L.P. now owns 4,359 shares of the company’s stock valued at $617,000 after acquiring an additional 1,279 shares in the last quarter. Federation des caisses Desjardins du Quebec raised its stake in shares of Globe Life by 13.1% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 6,326 shares of the company’s stock valued at $885,000 after acquiring an additional 732 shares in the last quarter. HRT Financial LP raised its stake in shares of Globe Life by 31.7% in the fourth quarter. HRT Financial LP now owns 110,834 shares of the company’s stock valued at $15,501,000 after acquiring an additional 26,664 shares in the last quarter. Finally, Brooklyn Investment Group raised its stake in shares of Globe Life by 30.6% in the fourth quarter. Brooklyn Investment Group now owns 2,874 shares of the company’s stock valued at $407,000 after acquiring an additional 673 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Performance

Shares of GL stock opened at $166.75 on Friday. The stock’s 50-day moving average is $152.88 and its two-hundred day moving average is $144.52. The firm has a market cap of $12.95 billion, a price-to-earnings ratio of 11.53 and a beta of 0.49. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $168.27. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts predict that Globe Life Inc. will post 15.64 earnings per share for the current year.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Insider Transactions at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 15,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the transaction, the chief financial officer owned 45,335 shares of the company’s stock, valued at approximately $6,965,722.75. This trade represents a 25.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Clay Majors sold 34,000 shares of the firm’s stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the transaction, the executive vice president directly owned 53,518 shares in the company, valued at approximately $8,231,603.58. The trade was a 38.85% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 105,929 shares of company stock worth $16,382,450. 2.11% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on GL. Truist Financial increased their price objective on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a report on Thursday, March 26th. Texas Capital raised Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Finally, Morgan Stanley increased their target price on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $174.11.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.